ClinicalTrials.gov record

Completed Not applicable Interventional Accepts healthy volunteers Results available

COVID-19 Testing and Vaccine Literacy for Women With Criminal Legal System Involvement

ClinicalTrials.gov ID: NCT05582746

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT05582746. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 12, 2026, 8:28 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Localized mHealth Approach to Boosting COVID-19 Testing and Vaccine Literacy, Access, and Uptake Among Women With Criminal Legal System Involvement

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this research is to use a localized mHealth intervention to boost COVID-19 testing and vaccine literacy, access, and uptake among women with CLSI

Study identification

NCT ID: NCT05582746
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: University of Kansas Medical Center; Other
Enrollment: 295 participants

Conditions and interventions

Conditions

COVID-19 Pandemic

Interventions

Tri-City COVID Attitudes Study Behavioral

Behavioral

Eligibility (public fields only)

Age range: 18 Years and older
Sex: Female
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 15, 2022 (Actual)
Primary completion: Oct 23, 2024 (Actual)
Completion: Oct 23, 2024 (Actual)
Last update posted: Jan 30, 2025

2022 – 2024

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
University of Kansas Medical Center	Kansas City	Kansas	66160	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05582746, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 30, 2025 · Synced Nov 12, 2026